MabThera Roche

Blood cancer injection given green light

August 5, 2014
Research and Development, Sales and Marketing MabThera, Roche, follicular lymphoma and small lymphocytic lymphoma

Roche has launched a new injection formulation of its blood cancer drug MabThera (rituximab) to treat patients with follicular lymphoma, …

Gene silencing back on the books for Roche

August 5, 2014
Research and Development, Sales and Marketing RNA, Roche, Santaris, gene silencing

Roche will pay $450 million to acquire the RNA specialist firm Santaris Pharma in order to once again begin research …

morya_knight

Astellas hires Moyra Knight as head of comms

August 4, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Astellas has appointed industry veteran Moyra Knight as its new head of corporate and employee communications in the Americas region. …

pm_awards_2014

PM Society announces Digital Media Awards finalists

August 4, 2014
Medical Communications, Research and Development, Sales and Marketing awards, digital, pm society

The finalists for the 2014 PM Society digital media awards have been announced as pharma and med comms agencies get …

abpi_reception

ABPI president: NICE needs political reform

August 1, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, NICE, Pfizer, jonathan emms, vba

Jonathan Emms, the new president of the ABPI, is a man not shy about defending the rights of the UK …

Minister calls for end of animal testing

August 1, 2014
Research and Development, Sales and Marketing Animal testing

British MP Norman Baker has called for an end to all animal testing in the UK and promised to increase …

david_cameron_3

Genomes Project gains £300m UK funding boost

August 1, 2014
Medical Communications, Research and Development, Sales and Marketing Genomics england, Illumina, NHS England, david cameron, genomes

A new funding stream aimed at helping British scientists map human DNA code will ‘revolutionise medicine’, according to prime minister …

boehringer_angle_22

Boehringer’s Striverdi gains FDA approval

August 1, 2014
Sales and Marketing Advair, COPD, Pfizer, Spiriva, asthma, olodaterol

Boehringer Ingelheim’s new lung drug Striverdi has gained US approval for patients with chronic obstructive pulmonary disorder. Striverdi Respimat (olodaterol), …

astrazeneca-headquarters_low_res

AstraZeneca’s second quarter beats estimates

July 31, 2014
Research and Development, Sales and Marketing AstraZeneca, Nexium, Pfizer

AstraZeneca posted a set of healthy financial results today as key platforms performed well for the company. Revenue in the …

Proteus digital pill

‘Smart pill’ creator gains new funding

July 31, 2014
Medical Communications, Research and Development, Sales and Marketing digital medicine, proteus, smart pills

Proteus Digital Health has raised $172 million to help develop its new brand of smart pills that can help patients …

Cause of rare childhood cancer discovered

July 31, 2014
Research and Development, Sales and Marketing Cancer, RMS, YAP, childhood cancer

Scientists have made a breakthrough in understanding the cause of a rare childhood muscle cancer, called Rhabdomyosarcoma (RMS). Around 60 …

tim_tonic

Tonic expands leadership team with two new hires

July 31, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Tonic Life Communications, the PR arm for Huntsworth Health, has added Tracey Carey as its new head of consumer and …

celgene_1_02_1

NICE won’t back Revlimid in new setting

July 31, 2014
Medical Communications, Sales and Marketing Celgene, NICE, Revlimid, Thalidomide, multiple myeloma

NICE has once again said it does not think that Celgene’s rare cancer drug Revlimid should be used on the …

David Cameron PM

Dementia diagnoses on the rise

July 30, 2014
Medical Communications, Research and Development, Sales and Marketing Alzheimer's, david cameron, dementia

The number of patients in England diagnosed with dementia has increased by 62% over seven years according to provisional figures …

steven_bradshaw

MKTXS appoints Dr Steven Bradshaw as director

July 30, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Global healthcare strategy firm MKTXS has appointed British medical research expert Dr Steven Bradshaw as its new European director. Market …

AstraZeneca secures respiratory drugs from Almirall

July 30, 2014
Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, Symbicort, lung drugs

AstraZeneca has paid $875 million to take control of Alimirall’s respiratory drug portfolio that includes treatments for bronchitis and emphysema. …

Amgen HQ

Amgen to wield axe on 2,900 jobs

July 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Enbrel, Prolia, job cuts

Amgen has announced this morning that it will make swingeing cuts in the US over the next two years as …

Pfizer New York HQ

Pfizer revenue drops, but new cancer drugs shine

July 29, 2014
Research and Development, Sales and Marketing Cancer, Inlyta. axitinib, Lipitor, Lyrica, Pfizer, Q2, Sutent, viagra

Pfizer saw a 2% drop in sales for the second quarter but has pointed to the stellar growth of its …

atorvastatin

Copycat Lipitor helps toward £1.3bn NHS savings

July 29, 2014
Research and Development, Sales and Marketing ABPI, Lipitor, NHS, Teva, prescribing PPRS, vba

In 2013 generic usage increased to more than three-quarters of all NHS prescriptions according to new data released by the …

The Gateway to Local Adoption Series

Latest content